Senate Majority Leader Bill Frist, R-TN, asked pharmaceutical marketers Friday to voluntarily stop direct-to-consumer advertising during a drug's first two years on the market. Going a step further,
Frist also wants a General Accountability Office review of Food and Drug Administration oversight of prescription drug activities and the industry's spending on these ads, according to a published CNP
report.
Read the whole story at DMNews.com, July 5, 2005 »